Abstract
A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.
Original language | English |
---|---|
Pages (from-to) | 6001-6003 |
Number of pages | 3 |
Journal | Chemical Communications |
Volume | 48 |
DOIs | |
Publication status | Published - 2012 |
Keywords
- Enzymes
- Escherichia coli
- Flavins
- Humans
- Mixed Function Oxygenases
- Moclobemide
- Journal Article
- Research Support, Non-U.S. Gov't
Fields of Expertise
- Human- & Biotechnology
Treatment code (Nähere Zuordnung)
- Experimental
- Application